Esperion Therapeutics Inc...

NASDAQ: ESPR · Real-Time Price · USD
2.15
0.08 (3.86%)
At close: Aug 15, 2025, 9:56 AM

Esperion Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.96 -1.47 -1.44 -0.45
PEG Ratio
0.09 0.03 0.02 -0.01
PS Ratio
1.24 2.65 5.48 1.84
PB Ratio
-1.06 -0.68 -0.31 -0.13
P/FCF Ratio
-17.18 -2.28 -2.37 -0.55
P/OCF Ratio
-17.41 -2.28 -2.37 -0.55
OCF/S Ratio
-0.07 -1.16 -2.32 -3.36
Debt / Equity Ratio
-1.52 -1.19 -0.19 -0.24
Quick Ratio
0.99 0.87 2.29 4.02
Current Ratio
1.37 1.29 2.67 4.48
Asset Turnover
0.97 0.57 0.30 0.21
Interest Coverage
0.92 -2.64 -3.16 -4.89
Return on Equity
0.13 0.46 0.21 0.29
Return on Assets
-0.15 -1.02 -1.16 -0.84
Return on Invested Capital
0.27 -1.81 -1.22 -0.84
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.79 0.63 0.64 0.82
Net Profit Margin
-0.16 -1.8 -3.81 -4.06
Pretax Profit Margin
-0.16 -1.8 -3.1 -3.43
Operating Profit Margin
0.16 -1.34 -2.38 -2.89
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.02 -1.29 -2.34 -2.83